Sensus Healthcare, Inc.

NasdaqCM:SRTS Stock Report

Market Cap: US$76.0m

Sensus Healthcare Future Growth

Future criteria checks 2/6

Sensus Healthcare is forecast to grow earnings and revenue by 3.9% and 12.9% per annum respectively while EPS is expected to grow by 3.6% per annum.

Key information

3.9%

Earnings growth rate

3.6%

EPS growth rate

Medical Equipment earnings growth12.1%
Revenue growth rate12.9%
Future return on equityn/a
Analyst coverage

Low

Last updated04 Apr 2025

Recent future growth updates

Revenue Beat: Sensus Healthcare, Inc. Beat Analyst Estimates By 5.6%

Feb 08
Revenue Beat: Sensus Healthcare, Inc. Beat Analyst Estimates By 5.6%

Results: Sensus Healthcare, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 19
Results: Sensus Healthcare, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Recent updates

Investors Shouldn't Be Too Comfortable With Sensus Healthcare's (NASDAQ:SRTS) Earnings

Mar 13
Investors Shouldn't Be Too Comfortable With Sensus Healthcare's (NASDAQ:SRTS) Earnings

Sensus Healthcare, Inc. (NASDAQ:SRTS) Stock's 27% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Feb 25
Sensus Healthcare, Inc. (NASDAQ:SRTS) Stock's 27% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Revenue Beat: Sensus Healthcare, Inc. Beat Analyst Estimates By 5.6%

Feb 08
Revenue Beat: Sensus Healthcare, Inc. Beat Analyst Estimates By 5.6%
author-image

SRTS Market Outlook

Jan 07Sensus Healthcare (NASDAQ: SRTS) operates in the Healthcare sector and is part of the Medical Devices industry. Specifically, it focuses on the development and commercialization of non-invasive Superf

We Think Sensus Healthcare (NASDAQ:SRTS) Might Have The DNA Of A Multi-Bagger

Dec 18
We Think Sensus Healthcare (NASDAQ:SRTS) Might Have The DNA Of A Multi-Bagger

Results: Sensus Healthcare, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 19
Results: Sensus Healthcare, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Sensus Healthcare, Inc. (NASDAQ:SRTS) Doing What It Can To Lift Shares

Nov 12
Sensus Healthcare, Inc. (NASDAQ:SRTS) Doing What It Can To Lift Shares

At US$6.10, Is It Time To Put Sensus Healthcare, Inc. (NASDAQ:SRTS) On Your Watch List?

Oct 03
At US$6.10, Is It Time To Put Sensus Healthcare, Inc. (NASDAQ:SRTS) On Your Watch List?
author-image

Fair Deal Agreement And Global Expansion Set To Revolutionize Revenue And Margins

Sep 28 Strategic shift towards recurring revenue with the Fair Deal Agreement model indicates potential for significant revenue growth from 2025.

Returns At Sensus Healthcare (NASDAQ:SRTS) Are On The Way Up

May 12
Returns At Sensus Healthcare (NASDAQ:SRTS) Are On The Way Up

Potential Upside For Sensus Healthcare, Inc. (NASDAQ:SRTS) Not Without Risk

Apr 16
Potential Upside For Sensus Healthcare, Inc. (NASDAQ:SRTS) Not Without Risk

Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 11
Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

There's Been No Shortage Of Growth Recently For Sensus Healthcare's (NASDAQ:SRTS) Returns On Capital

Oct 17
There's Been No Shortage Of Growth Recently For Sensus Healthcare's (NASDAQ:SRTS) Returns On Capital

Sensus Healthcare (NASDAQ:SRTS) Might Have The Makings Of A Multi-Bagger

Jul 04
Sensus Healthcare (NASDAQ:SRTS) Might Have The Makings Of A Multi-Bagger

Lacklustre Performance Is Driving Sensus Healthcare, Inc.'s (NASDAQ:SRTS) 26% Price Drop

Mar 14
Lacklustre Performance Is Driving Sensus Healthcare, Inc.'s (NASDAQ:SRTS) 26% Price Drop

Do Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?

Mar 06
Do Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?

Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger

Oct 11
Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger

Sensus Healthcare Q2 GAAP EPS, revenue beats

Aug 04

Sensus Healthcare: A Buy In Honor Of Skin Cancer Awareness Month

May 21

Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts

May 11
Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts

Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist

Apr 29
Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist

Earnings and Revenue Growth Forecasts

NasdaqCM:SRTS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2027639N/AN/A2
12/31/20265510N/AN/A4
12/31/2025425N/AN/A5
12/31/2024427-1-1N/A
9/30/202441923N/A
6/30/2024367-1-1N/A
3/31/2024325-5-4N/A
12/31/2023240-2-2N/A
9/30/202325-1-15-15N/A
6/30/2023302-12-12N/A
3/31/2023386-11-10N/A
12/31/20224524-2-1N/A
9/30/2022442777N/A
6/30/2022412544N/A
3/31/2022342144N/A
12/31/202127400N/A
9/30/202119011N/A
6/30/202115-2-3-3N/A
3/31/202111-4-2-2N/A
12/31/202010-7-10N/A
9/30/202013-700N/A
6/30/202017-611N/A
3/31/202024-355N/A
12/31/201927-2-3-2N/A
9/30/201927-3-5-4N/A
6/30/201927-2-5-5N/A
3/31/201926-3-13-12N/A
12/31/201826-2-9-9N/A
9/30/201825-3N/A-6N/A
6/30/201823-3N/A-5N/A
3/31/201822-3N/A-4N/A
12/31/201721-4N/A-3N/A
9/30/201719-3N/A-2N/A
6/30/201718-2N/A-3N/A
3/31/201716-2N/A-3N/A
12/31/2016150N/A-1N/A
9/30/2016140N/A-2N/A
6/30/2016130N/A-1N/A
3/31/2016110N/A-1N/A
12/31/201510-1N/A-1N/A
9/30/20158-2N/A-1N/A
12/31/20146-4N/A-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SRTS's forecast earnings growth (3.9% per year) is above the savings rate (2.8%).

Earnings vs Market: SRTS's earnings (3.9% per year) are forecast to grow slower than the US market (13.6% per year).

High Growth Earnings: SRTS's earnings are forecast to grow, but not significantly.

Revenue vs Market: SRTS's revenue (12.9% per year) is forecast to grow faster than the US market (8.3% per year).

High Growth Revenue: SRTS's revenue (12.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if SRTS's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/13 17:31
End of Day Share Price 2025/04/11 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sensus Healthcare, Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrew D'SilvaB. Riley Securities, Inc.
Alexander NowakCraig-Hallum Capital Group LLC
Ilya ZubkovFreedom Broker